Coldtac Plus Softgels (Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride)
Brand Names: Coldtac Plus Softgels
Methodology & AI Transparency ⓘ
Coldtac Plus Softgels (Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride) Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Distinguished by trade identifier Coldtac Plus Softgels and registered by OPMX LLC., this sigma-1 agonist product delivers active pharmaceutical ingredient Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride (325 mg/1 / 10 mg/1 Capsule, Liquid Filled; 10 mg/1 / 325 mg/1 Capsule, Liquid Filled).
- 2 Real-world patient consensus: Coldtac Plus Softgels links directly to generic Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride under FDA SPL 2024-04-05 (NDC 69729-120).
- 3 Typical cash cost range: Public pharmacy ledger: $9.90 low cash benchmark vs. $34.50 chain retail average ($0.0194/unit CMS NADAC).
- 4 Top reported side effects / signs: Most commonly reported Coldtac Plus Softgels (Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride) tolerability events: headache (9.6%), cough (6.6%), application-site irritation (5.7%).
Ask our AI Specialists anything about Coldtac Plus Softgels (Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride)
Coldtac Plus Softgels (Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride) Mechanism, CYP450 Pathways & DailyMed Monograph
Distinguished by trade identifier Coldtac Plus Softgels and registered by OPMX LLC., this sigma-1 agonist product delivers active pharmaceutical ingredient Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride (325 mg/1 / 10 mg/1 Capsule, Liquid Filled; 10 mg/1 / 325 mg/1 Capsule, Liquid Filled). Federal labeling (2024-04-05, RxCUI 1086997-B69729120) defines its therapeutic scope: Uses Temporarily relieves common cold/flu symptoms: Nasal congestion Cough due to minor throat & bronchial irritation.
Inside Coldtac Plus Softgels, Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride mediates sigma-1 agonist pharmacodynamics with class-characteristic hepatorenal disposition across labeled adult regimens (325 mg/1 / 10 mg/1 Capsule, Liquid Filled; 10 mg/1 / 325 mg/1 Capsule, Liquid Filled). Commercial labeling registered by OPMX LLC. (SPL 2024-04-05, RxNorm 1086997-B69729120) pairs standardized excipient stability with federal price transparency metrics ($0.0194/unit NADAC; $34.50 retail average).
Following administration (325 mg/1 / 10 mg/1 Capsule, Liquid Filled), Coldtac Plus Softgels (Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride) achieves Systemic oral bioavailability of roughly 49%–61% following first-pass transit bioavailability and initial pharmacodynamic onset within 1–3 hrs (peak cmax) for coldtac plus softgels (acetaminophen, dextromethorphan hydrobromide, phenylephrine hydrochloride) onset, governed by a Biphasic clearance with 5–11 hr terminal t½ under Coldtac Plus Softgels (Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride) maintenance terminal half-life through hepatic enzymatic processing and renal clearance proportional to creatinine clearance (coldtac plus softgels (acetaminophen, dextromethorphan hydrobromide, phenylephrine hydrochloride)).
Before initiating Coldtac Plus Softgels (Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride) at 325 mg/1 / 10 mg/1 Capsule, Liquid Filled, clinical safety checklists rule out known hypersensitivity to acetaminophen, dextromethorphan hydrobromide, phenylephrine hydrochloride or structurally related sigma-1 agonist compounds; concomitant contra-labeled cyp/transporter therapies during active coldtac plus softgels (acetaminophen, dextromethorphan hydrobromide, phenylephrine hydrochloride) administration. Logged tolerability patterns center on headache (9.6% of reports), nausea (7.7% of reports), cough (6.6% of reports).
Avoid overlapping sigma-1 agonist prescriptions alongside Coldtac Plus Softgels (Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride) to prevent cumulative receptor toxicity.
Botanical enzyme modulators may alter oral first-pass exposure of Coldtac Plus Softgels (Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride); disclose all supplements.
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- Known hypersensitivity to Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride or structurally related sigma-1 agonist compounds
- Concomitant contra-labeled CYP/transporter therapies during active Coldtac Plus Softgels (Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride) administration
Logged Side-Effect Incidence (12 Reports)
Coldtac Plus Softgels (Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride) Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Coldtac Plus Softgels (Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride))
Human clinical trial evidence for Coldtac Plus Softgels (Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride) is indexed directly from the U.S. National Library of Medicine NCBI PubMed database. Explore recent randomized trials in the PubMed Research Pulse .
Coldtac Plus Softgels (Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride) Public Price Transparency Ledger
| Dispensing Channel / Benchmark | Verification Source | Reference Cost | Details |
|---|---|---|---|
| Pharmacy Acquisition Cost (CMS NADAC) | CMS Medicaid NADAC Weekly National Survey | $0.0194/unit (~$0.58/30u) | Wholesale baseline |
| Average U.S. Walk-In Retail Cash Price | Chain Pharmacy Uninsured Cash Index | $34.50 / mo | Before coupon/insurance |
| Patient-Logged Out-of-Pocket Average | 12 Anonymous DotMD Community Micro-Logs | $9.90 / mo | View logs ↓ |
Coldtac Plus Softgels (Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride) Federal Verification & Benchmark Summary
| Metric | Verified Benchmark | Source |
|---|---|---|
| Coldtac Plus Softgels (Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride) RxNorm Concept ID | 1086997-B69729120 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $0.0194 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $34.50 / mo | U.S. Uninsured Retail Cash Index |
| Public Mail-Order Wholesale Benchmark | $9.90 / mo (Patient Mean) | Public Cash Reference |
| Real-World Patient Consensus | 85.00% Worth It (12 anonymous logs) | DotMD Zero-PHI Patient Ledger |
Coldtac Plus Softgels (Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride) Patient Community, Cohort Filters & Dosage Logs
Federal clinical ledger for Coldtac Plus Softgels (Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride) integrating DailyMed SPL (2024-04-05), CMS NADAC ($0.0194/unit), and 12 Zero-PHI patient logs.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Filter Coldtac Plus Softgels (Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride) community threads and patient logs by age, biological sex, dosage, and treatment duration.